A new guidance note has been issued by the CMDv, regarding so-called ‘partial MAH transfer’. The document contains requirements and best practice recommendations to manage the situation where a product authorised via DCP or MRP has been transferred to another MAH in some, but not all, Member States (Link).
Regulatory Outsourcing Options
Cyton’s dedicated regulatory procedures team can support you with:
- Dossier preparation, submission & regulatory procedures
- Regulatory intelligence and strategic planning
- Life cycle management
- Key person cover
- Pharmacovigilance
- Brexit support services